A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections-Reference-Cited by-同舟云学术

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Published:2008-03-01 Issue:5 Volume:46 Page:647-655
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Noel G. J.,Bush K.,Bagchi P.,Ianus J.,Strauss R. S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/46/5/647/805779/46-5-647.pdf

Reference21 articles.

1. Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections

2. Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

3. Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections

4. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?

5. Can β-lactams be re-engineered to beat MRSA?

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of MRSA Infection: Where are We?;Current Medicinal Chemistry;2024-08

2. Ceftobiprole mono-therapy versus combination or non-combination regimen of standard antibiotics for the treatment of complicated infections: A systematic review and meta-analysis;Diagnostic Microbiology and Infectious Disease;2024-07

3. Microbiological profile of diabetic foot infections in China and worldwide: a 20-year systematic review;Frontiers in Endocrinology;2024-06-28

4. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future;Expert Opinion on Drug Safety;2023-12-25

5. Interventions in the management of diabetes‐related foot infections: A systematic review;Diabetes/Metabolism Research and Reviews;2023-10-10